204 related articles for article (PubMed ID: 19121624)
21. [The ribonucleotide reductase enzyme as a target for enzyme-directed chemotherapy effects of trimidox (3,4,5-trihydroxybenzohydroxamidoxim), a new inhibitor of ribonucleotide reductases].
Findenig G; Vielnascher E; Göbl R; Fritzer-Szekeres M; Szekeres T
Wien Klin Wochenschr; 1995; 107(22):694-7. PubMed ID: 8533431
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive and nondestructive optical spectroscopic measurement of motexafin gadolinium in mouse tissues: comparison to high-performance liquid chromatography.
Kanick SC; Eiseman JL; Joseph E; Guo J; Parker RS
J Photochem Photobiol B; 2007 Sep; 88(2-3):90-104. PubMed ID: 17604637
[TBL] [Abstract][Full Text] [Related]
23. Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation.
Ramos J; Sirisawad M; Miller R; Naumovski L
Mol Cancer Ther; 2006 May; 5(5):1176-82. PubMed ID: 16731749
[TBL] [Abstract][Full Text] [Related]
24. Overview of ribonucleotide reductase inhibitors: an appealing target in anti-tumour therapy.
Cerqueira NM; Pereira S; Fernandes PA; Ramos MJ
Curr Med Chem; 2005; 12(11):1283-94. PubMed ID: 15974997
[TBL] [Abstract][Full Text] [Related]
25. Visualization of ribonucleotide reductase catalytic oxidation establishes thioredoxins as its major reductants in yeast.
Camier S; Ma E; Leroy C; Pruvost A; Toledano M; Marsolier-Kergoat MC
Free Radic Biol Med; 2007 Apr; 42(7):1008-16. PubMed ID: 17349928
[TBL] [Abstract][Full Text] [Related]
26. 5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-beta-D-arabinofuranosyluracil, -cytosine, and -adenine: inhibition of ribonucleotide reductase.
Manfredini S; Baraldi PG; Durini E; Vertuani S; Balzarini J; De Clercq E; Karlsson A; Buzzoni V; Thelander L
J Med Chem; 1999 Aug; 42(17):3243-50. PubMed ID: 10464011
[TBL] [Abstract][Full Text] [Related]
27. Ribonucleotide reductase: a critical enzyme for cancer chemotherapy and antiviral agents.
Cerqueira NM; Fernandes PA; Ramos MJ
Recent Pat Anticancer Drug Discov; 2007 Jan; 2(1):11-29. PubMed ID: 18221051
[TBL] [Abstract][Full Text] [Related]
28. Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2'-azido-2'-deoxynucleosides.
Roy B; Verri A; Lossani A; Spadari S; Focher F; Aubertin AM; Gosselin G; Mathé C; Périgaud C
Biochem Pharmacol; 2004 Aug; 68(4):711-8. PubMed ID: 15276078
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ribonucleotide reductase by caracemide.
Moore EC; Loo TL
Cancer Treat Rep; 1984 Oct; 68(10):1293-4. PubMed ID: 6395952
[TBL] [Abstract][Full Text] [Related]
30. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine.
Pereira S; Fernandes PA; Ramos MJ
J Comput Chem; 2004 Jul; 25(10):1286-94. PubMed ID: 15139041
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory mechanisms of heterocyclic carboxaldehyde thiosemicabazones for two forms of human ribonucleotide reductase.
Zhu L; Zhou B; Chen X; Jiang H; Shao J; Yen Y
Biochem Pharmacol; 2009 Nov; 78(9):1178-85. PubMed ID: 19576866
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of action of peptide inhibitors of mammalian ribonucleotide reductase targeting quaternary structure.
Gao Y; Kashlan OB; Kaur J; Tan C; Cooperman BS
Biopolymers; 2005; 80(1):9-17. PubMed ID: 15586357
[TBL] [Abstract][Full Text] [Related]
33. Design and virtual screening towards synthesis of novel substituted thiosemicarbozones as ribonuleotide reductase (RNR) inhibitors with improved cellular trafficking and anticancer activity.
Gokhale N; Jain S; Yadav M
Curr Top Med Chem; 2015; 15(1):37-42. PubMed ID: 25579572
[TBL] [Abstract][Full Text] [Related]
34. DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2).
Chen CW; Li Y; Hu S; Zhou W; Meng Y; Li Z; Zhang Y; Sun J; Bo Z; DePamphilis ML; Yen Y; Han Z; Zhu W
Oncogene; 2019 Mar; 38(13):2364-2379. PubMed ID: 30518875
[TBL] [Abstract][Full Text] [Related]
35. Theoretical studies on the mode of inhibition of ribonucleotide reductase by 2'-substituted substrate analogues.
Fernandes PA; Ramos MJ
Chemistry; 2003 Dec; 9(23):5916-25. PubMed ID: 14673863
[TBL] [Abstract][Full Text] [Related]
36. Intracellular localization of the radiation enhancer motexafin gadolinium using interferometric Fourier fluorescence microscopy.
Woodburn KW
J Pharmacol Exp Ther; 2001 Jun; 297(3):888-94. PubMed ID: 11356908
[TBL] [Abstract][Full Text] [Related]
37. Gadolinium texaphyrin-methotrexate conjugates. Towards improved cancer chemotherapeutic agents.
Wei WH; Fountain M; Magda D; Wang Z; Lecane P; Mesfin M; Miles D; Sessler JL
Org Biomol Chem; 2005 Sep; 3(18):3290-6. PubMed ID: 16132091
[TBL] [Abstract][Full Text] [Related]
38. A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance.
Zhou B; Su L; Hu S; Hu W; Yip ML; Wu J; Gaur S; Smith DL; Yuan YC; Synold TW; Horne D; Yen Y
Cancer Res; 2013 Nov; 73(21):6484-93. PubMed ID: 24072748
[TBL] [Abstract][Full Text] [Related]
39. Development of ribonucleotide reductase inhibitors: a review on structure activity relationships.
Moorthy NS; Cerqueira NM; Ramos MJ; Fernandes PA
Mini Rev Med Chem; 2013 Nov; 13(13):1862-72. PubMed ID: 24032510
[TBL] [Abstract][Full Text] [Related]
40. A novel assay revealed that ribonucleotide reductase is functionally important for interstrand DNA crosslink repair.
Fujii N; Evison BJ; Actis ML; Inoue A
Bioorg Med Chem; 2015 Nov; 23(21):6912-21. PubMed ID: 26462050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
